This review explores how GMO tomatoes could increase bifidobacterium and improve gut health, highlighting key biochemical pathways.
Within the past decades, there has been a noticeable decrease in the microbiome of the population, which corresponds to probiotic intake and the production of bifidobacterium in the human body. 020402_LYZ M1, a lysozyme-like protein which is produced by Bifidobacterium longum (B. Longum), would hypothetically increase the nutritional value of a tomato when genetically engineering a tomato plant with this protein. This research review explores the main reasons this GMO would succeed in the real world and describes its other effects on plants, immunity, the biochemical pathways of the plants, and human gut health. The main hypothesis of this paper is to state that the 020402_LYZ M1 protein can make a tomato plant produce more B. longum in the tomato to increase the growth of good bacteria in the human gut while also reducing gut inflammation.
No takes yet. Share an insight, caveat, or question.
Diya Chivukula (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: